Abstract
Prognostic Value of High-Sensitivity C-Reactive Protein and Lipoprotein (a) in Acute Myocardial Infarction Patients Receiving Emergency Percutaneous Coronary InterventionIn order to study the prognostic value of high-sensitivity C-reactive protein (hsCRP) and lipoprotein (a) [Lp(a)] in patients receiving emergency percutaneous coronary intervention (PCI) following acute myocardial infarction (AMI), we retrospectively reviewed 118 patients who received emergency PCI following AMI from January 2007 to April 2010. The plasma levels of hsCRP and Lp(a) were determined. The incidence of cardiovascular events was compared between patients with an elevated hsCRP level and those with a normal hsCRP level and between patients with an elevated Lp(a) level and those with a normal Lp(a) level. Results showed that the incidence of cardiovascular events was 52.9% in the hsCRP-elevated group and 18.2% in the hsCRP-normal group displaying a significant difference (P=0.011). However, the incidence of cardiovascular events was 35.3% in the Lp(a)-elevated group and 46.4% in the Lp(a)-normal group and statistical analysis revealed no significant difference (P=0.733). HsCRP, but not Lp(a), can serve as a prognostic factor for patients receiving emergency PCI following AMI.
Highlights
Acute myocardial infarction (AMI) is the most severe type of coronary heart disease (CHD) and threatens the human health
Summary: In order to study the prognostic value of highsensitivity C-reactive protein and lipoprotein (a) [Lp(a)] in patients receiving emergency percutaneous coronary intervention (PCI) following acute myocardial infarction (AMI), we retrospectively reviewed 118 patients who received emergency PCI following AMI from January 2007 to April 2010
The incidence of cardiovascular events was compared between patients with an elevated highsensitivity C-reactive protein (hsCRP) level and those with a normal hsCRP level and between patients with an elevated Lp(a) level and those with a normal Lp(a) level
Summary
Acute myocardial infarction (AMI) is the most severe type of coronary heart disease (CHD) and threatens the human health. Ding et al.: High-sensitivity C reactive protein and lipoprotein (a) in acute myocardial infarction patients with ST segment elevation or high risk. There is still a fraction of patients who develop several complications including cardiogenic shock, heart failure and severe arrhythmia following emergency primary PCI, which results in death or decrease in quality of life. Screening these patients is helpful to take timely measures to reduce the mortality and the complications of AMI. High sensitivity C-reactive protein (hsCRP) and lipoprotein (a) [Lp(a)] have been demonstrated to be independent risk factors for cardiovascular events in patients with CHD [3, 4]. The levels of hsCRP and Lp(a) were measured and the prognostic value of both parameters was evaluated in these patients
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
